Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing risperidone to placebo in children with autism spectrum disorder and related pervasive developmental disorders has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asperger Syndrome
• Autism Spectrum Disorder
• Developmental Disabilities
• Pervasive Developmental Disorders
• Rett Syndrome

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: DCild Development Disorders, Pervasive, Autistic Disorder | Phase 3 | Status: COMPLETED